Thu, March 2, 2023
Wed, March 1, 2023
Tue, February 28, 2023

Madhu Kumar Maintained (SNDX) at Strong Buy with Decreased Target to $34 on, Mar 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-34-on-mar-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Madhu Kumar of Goldman Sachs, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy with Decreased Target from $39 to $34 on, Mar 1st, 2023.

Madhu has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Madhu's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Madhu


  • Bradley Canino of "Stifel" Initiated at Strong Buy and Held Target at $37 on, Tuesday, January 31st, 2023
  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $41 on, Tuesday, January 3rd, 2023

Publication Contributing Sources